New heterocyclic carboxamides for use as thrombin inhibitors

Details for Australian Patent Application No. 2009263076 (hide)

Owner AstraZeneca AB

Inventors Branalt, Jonas; Nilsson, Ingemar; Polla, Magnus; Gustafsson, David

Agent Davies Collison Cave

Pub. Number AU-B-2009263076

PCT Pub. Number WO2009/157860

Priority 61/074,736 23.06.08 US; 61/102,381 03.10.08 US

Filing date 22 June 2009

Wipo publication date 30 December 2009

Acceptance publication date 26 July 2012

International Classifications

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4155 - not condensed and containing further heterocyclic rings

A61K 31/422 - not condensed and containing further heterocyclic rings

A61P 7/02 Drugs for disorders of the blood or the extracellular fluid

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/157860 Priority application(s): WO2009/157860

26 July 2012 Application Accepted

  Published as AU-B-2009263076

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009263080-Tree delimbing method and device

2009263074-Use of cyclolignans for the treatment of a hyperactive immune system